Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2002
Business Overview: The company operates outpatient physical and occupational therapy clinics providing post-operative care and treatment for orthopedic and sports-related injuries. As of September 30, 2002, the company operated 190 clinics in 31 states and managed six additional facilities for third parties.
Key Financial Metrics
All figures in thousands, except per share data.
| Metric | Three Months Ended Sep 30, 2002 | Nine Months Ended Sep 30, 2002 |
|---|---|---|
| Net Revenues | $23,811 | $70,112 |
| Net Income | $2,018 | $6,430 |
| Diluted EPS | $0.16 | $0.50 |
| Operating Cash Flow | N/A | $15,498 |
| Cash and Equivalents | $8,977 (Sep 30, 2002) | N/A |
| Debt-to-Equity Ratio | 0.07 to 1.00 | N/A |
| Current Ratio | 7.74 to 1.00 | N/A |
Debt Profile: Long-term debt consists primarily of $2,333,000 in Convertible Subordinated Notes (Series C) due June 30, 2004. Total current liabilities were $3,166,000.
Material Changes vs. Prior Period
- Revenue Growth: Net patient revenues increased 16% ($3.3M) for the quarter and 19% ($10.8M) for the nine months compared to the prior year periods. Growth was driven by 36 new clinics (contributing 44% of Q3 revenue growth) and increased visits at mature clinics.
- Profitability: Net income rose 11% for the quarter and 25% for the nine months. Operating income increased due to higher visit volumes and improved collection efforts, which reduced the provision for doubtful accounts.
- Cost Structure: Clinic operating costs remained stable at 68% of revenues for the quarter and decreased to 67% for the nine months. Corporate office costs increased 28% for the quarter due to hiring additional personnel to support clinic expansion.
- Capital Structure: The company significantly reduced debt by converting $667,000 of subordinated notes into common stock in June 2002. Additionally, the company repurchased 550,000 shares of common stock for $7.8M during the period.
Guidance, Outlook, and Risks
- Expansion Goals: Management aims to open between 35 and 40 clinics in 2002. New clinics are expected to incur initial operating losses but will favorably impact results over the subsequent two to three years.
- Liquidity: The company holds $8.98M in cash and cash equivalents. Management believes existing funds and operating cash flows are sufficient to meet needs through 2003 without external credit lines.
- Regulatory Risk (Medicare): A moratorium on the $1,500 annual reimbursement limit for Medicare therapy services is set to expire December 31, 2002. Management does not anticipate a material impact if the limit becomes effective in 2003, as they generally do not treat long-term complicated rehabilitation cases.
- Economic Factors: Management noted that visit growth in Q3 2002 was negatively impacted by the general economy, while Q1 growth was affected by a mild winter reducing weather-related injuries.
Investor Verification Checklist
- Medicare Reimbursement: Verify the status of the $1,500 Medicare cap moratorium and potential impact on 2003 revenue if the limit is reinstated.
- Stock Repurchase Program: Confirm the remaining authorization under the $1M share buyback program (785,000 shares purchased as of October 2002).
- Debt Conversion: Monitor the remaining $2.33M convertible subordinated notes due in 2004 and potential future conversions.
- New Clinic Performance: Track the ramp-up period and profitability timeline for the 36 clinics opened since late 2001.
- Minority Interest Acquisitions: Review the financial impact of recent purchases of minority partnership interests in clinic limited partnerships.